Trial
NCT03978156
Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Sickle Cell Disease
Intervention
Dronabinol 2.5 MG
Why stopped
Covid-19. Relocation of trainee/investigator. Covid-19.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-26